In pediatric bradycardia, what should be done if there is no response to epinephrine?
Select Your Answer:
In pediatric bradycardia, atropine should be administered if no response to epinephrine and only if vagal or cholinergic drug toxicity cause. Hypoxemia is the number one cause of bradycardia in the pediatric population. NOTE: Oxygenate and ventilate, if this fails give Epinephrine IV in a poorly perfusing patient.
Atropine may be repeated only once in pediatric bradycardia. Atropine dose is 0.02 mg/kg IV or IO, minimum dose of 0.1 mg and max single dose of 0.5 mg. Poor perfusion requires emergency intervention. Cap refill of over 2 seconds, hypotension, faint pulses, altered level of consciousness and cool skin can signify poor perfusion that requires life saving interventions.
Epinephrine 0.01mg/kg (1:10,000) or 0.1 ml/kg may be administered every 3 to 5 minutes IV or IO. External pacing can be considered. Transcutaneous pacing is painful and sedation should be considered. Adult size pacer pads are used if over 10 kg. Demand rate setting starts at 100 and MA is adjusted until capture. A pediatric resuscitation tape will be useful.
Remember to provide oxygen and ventilate, if heart rate less than 60 with poor perfusion then chest compressions should be initiated. Pediatric bradycardia is defined as a heart rate of less than a child's normal heart rate according to their age unless a highly trained athlete.
*eMedicine, Google Scholar, UpToDate, WheelessOnline, and DermNet are not affiliated with StatPearls. We do not control their content or advertising.
Adult Lab Normals
Pediatric Lab Normals
Sinus node dysfunction after surgical atrial fibrillation ablation with concomitant mitral valve surgery: Determinants and clinical outcomes., Kim D,Shim CY,Hong GR,Cho IJ,Lee SH,Chang HJ,Lee S,Ha JW,Chang BC,, PloS one, 2018 [PubMed PMID: 30208099]
In Vitro Analyses of Novel HCN4 Gene Mutations., Möller M,Silbernagel N,Wrobel E,Stallmayer B,Amedonu E,Rinné S,Peischard S,Meuth SG,Wünsch B,Strutz-Seebohm N,Decher N,Schulze-Bahr E,Seebohm G,, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018 Sep 7 [PubMed PMID: 30196304]
A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel., Ye D,Tester DJ,Zhou W,Papagiannis J,Ackerman MJ,, Heart rhythm, 2018 Aug 29 [PubMed PMID: 30172029]
Stability of intrinsic rhythm in pacemaker-dependent patients during pacemaker replacement: Can we predict the need for temporary pacing?, Kimura Y,Sumiyoshi M,Inoue K,Shiozaki M,Fukuda K,Fujiwara Y,Tabuchi H,Hayashi H,Sekita G,Tokano T,Nakazato Y,Daida H,, Journal of arrhythmia, 2018 Aug [PubMed PMID: 30167017]
Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade., Danielsson B,Webster WS,Ritchie HE,, Reproductive toxicology (Elmsford, N.Y.), 2018 Aug 24 [PubMed PMID: 30149139]